bpc 157 clinical trials fda status bpc-157 human evidence review safety warning Thinking about trying BPC-157? Read this first. While often marketed as a “healing peptide” BPC-157 is not FDA approved and not pharmacy grade BPC-157 Legal Status & Clinical

General inflammation markers not specific to musculoskeletal healing

The trial protocol was approved by the Madrid Region Clinical Research Ethics Committee ( Comit tico de Investigacin Clnica Regional de la Comunidad de Madrid ) on February 8 th 2011, and has been registered with ClinicalTrials.gov number NCT 01476007, and under EUDRACT number 2010-024129-20 [Oral Versus Intramuscular Cobalamin to treat Cobalamin Deficiency: Noninferiority randomised controlled trial, pragmatic and multi-center in the primary healthcare setting (OB12 project)]

These reactions are typically short-lived and resolve without intervention

10.1186/s13102-016-0045-x 25

Additionally, if you have any pre-existing health conditions, talk to your doctor before starting B12 supplements